EMA untersucht Thrombose-Fälle bei AstraZeneca weiter + hat bislang nichts gefunden:

„At present the review has not identified any specific risk factors, such as age, gender or a previous medical history of clotting disorders, for these very rare events.” https://t.co/up10iznd3s